SK Capital Partners has announced the closing of its latest fund with $2.95 billion in commitments.

The new fund, SK Capital Partners VI, was oversubscribed.

SK Capital Partners, based in New York, is a private equity firm focused on the life sciences and a few other sectors. The firm typically pursues control buyouts, recapitalizations and growth equity investments.